Nutanix (NTNX) Tops Q3 EPS by 8c, Revenues Beat

Nutanix (NTNX) Gains on Strong Q3 Results, Analysts Raise Estimates and PTs

Shares of Nutanix (NASDAQ: NTNX) are up almost 3% in todays trading session after the company reported better-than-expected results for its fiscal third quarter.

The company posted a net loss of $0.41 per share which was better than a 49-cent loss per share. Revenues for the quarter jumped 8.2% to $345 million to again top the $335 million expected from market analysts.

For the third quarter in a row, we delivered outperformance across all guided metrics and demonstrated our ability to execute consistently.

"We are also pleased with our progress on key priorities, including bolstering our... More

Nutanix (NTNX) PT Raised to $47 at Needham & Company

Needham & Company analyst Jack Andrews raised the price target on Nutanix (NASDAQ: NTNX) to $47.00 (from $43.00) while maintaining a Buy rating.

The analyst commented, "NTNX reported good 3QFY21 results as all key metrics (ACV, revenue, and EPS) were ahead of consensus. Management also... More

Nutanix (NTNX) PT Raised to $38 at Susquehanna

Susquehanna analyst Mehdi Hosseini raised the price target on Nutanix (NASDAQ: NTNX) to $38.00 (from $35.00) while maintaining a Positive rating.

The analyst commented, "It is encouraging to see Nutanix continue to gain traction with AHV adoption, which has reached 52%, while ACV Billings... More

Nutanix (NTNX) VAR Checks Point to Billings Upside - BofA Securities

BofA Securities analyst Wamsi Mohan reiterated a Buy rating and $39.00 price target on Nutanix (NASDAQ: NTNX) after checks indicate to solid traction at Nutanix focused VARs.

The analyst stated "We expect upside to ACV billings at $160mn vs. guidance of $150-155mn as... More